About SHSKX
BlackRock Health Sciences Opportunities Fund Class K is a mutual fund that primarily targets long-term capital appreciation by investing at least 80% of its assets in equity securities of companies within the health sciences and related industries. The fund’s portfolio emphasizes both growth and value stocks across diversified market capitalizations, aiming to capture opportunities from the innovation and expansion within global healthcare sectors. Its holdings span leading biotechnology, pharmaceutical, medical device, and healthcare service companies, with notable concentrations in firms such as Eli Lilly and Company, Boston Scientific Corporation, and AbbVie Inc. The fund leverages investment expertise informed by scientific experience, seeking to deliver diversified returns with lower volatility compared to sector peers. Managed by BlackRock, the fund distinguishes itself through comprehensive research and a disciplined approach, while maintaining a competitive expense structure. Although the fund closely monitors environmental, social, and governance factors for transparency, it does not follow a specific ESG mandate. This fund holds a significant role in providing investors with access to innovative healthcare equities and exposure to a critical, ever-evolving industry that is central to global economic and societal well-being.
Fund Family BlackRock
Category Health
Performance Rating Above Average
Risk Rating Low
Stock Exchange NASDAQ
Ticker Symbol SHSKX
Index Russell 3000 Healthcare TR
SHSKX had a total return of 32.05% in the past year, including dividends. Since the fund's
inception, the average annual return has been 12.42%.
